{"id":"csa-high-dose","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Nephrotoxicity"},{"rate":"20-30%","effect":"Hypertension"},{"rate":"10-20%","effect":"Diabetes mellitus"}]},"_chembl":{"chemblId":"CHEMBL3038082","moleculeType":"Protein","molecularWeight":"1361.89"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CsA works by inhibiting calcineurin, a protein phosphatase involved in the activation of T-lymphocytes.","oneSentence":"Calcineurin inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:42.893Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Organ transplantation"}]},"trialDetails":[{"nctId":"NCT06816134","phase":"PHASE2","title":"Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-01-30","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell","enrollment":48},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT04195633","phase":"PHASE2","title":"Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2021-01-25","conditions":"Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":60},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT06013423","phase":"PHASE2","title":"Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-07-23","conditions":"Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":54},{"nctId":"NCT06812598","phase":"NA","title":"Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-12-16","conditions":"Cytomegalovirus Infections, CMV","enrollment":330},{"nctId":"NCT07297550","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-12-15","conditions":"Severe Aplastic Anemia, Refractory Aplastic Anemia, Newly Diagnosed Aplastic Anemia","enrollment":42},{"nctId":"NCT03128034","phase":"PHASE1, PHASE2","title":"211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2017-10-24","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia","enrollment":75},{"nctId":"NCT07232277","phase":"","title":"Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-10-15","conditions":"Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury","enrollment":114},{"nctId":"NCT02143830","phase":"PHASE2","title":"HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2014-04","conditions":"Fanconi Anemia, Severe Marrow Failure, Myelodysplastic Syndrome (MDS)","enrollment":70},{"nctId":"NCT07164833","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)","status":"RECRUITING","sponsor":"Bilix Co.,Ltd.","startDate":"2025-08-26","conditions":"Ischemia Reperfusion Injury, Cardiac Surgery Associated - Acute Kidney Injury","enrollment":40},{"nctId":"NCT01282073","phase":"PHASE3","title":"Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2011-03","conditions":"Glomerulonephritis, Membranous","enrollment":43},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT04813653","phase":"PHASE1","title":"Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2021-04-18","conditions":"Multiple Myeloma in Relapse, Multiple Myeloma, Refractory","enrollment":3},{"nctId":"NCT03456817","phase":"PHASE2","title":"HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis","status":"TERMINATED","sponsor":"AHS Cancer Control Alberta","startDate":"2020-07-01","conditions":"Graft-versus-host-disease, Relapse","enrollment":68},{"nctId":"NCT07059156","phase":"PHASE2, PHASE3","title":"Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-06-01","conditions":"Acute Lymphoblastic Leukemia, Adult","enrollment":50},{"nctId":"NCT05855954","phase":"NA","title":"Application of CLCVP Technique in Early Intervention of CSA-AKI","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2023-05-01","conditions":"Acute Kidney Injury","enrollment":200},{"nctId":"NCT03434730","phase":"PHASE2","title":"Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-02-07","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia","enrollment":46},{"nctId":"NCT00866684","phase":"PHASE4","title":"Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2007-01-01","conditions":"Skin Cancer","enrollment":44},{"nctId":"NCT01623167","phase":"PHASE1, PHASE2","title":"Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2012-07-02","conditions":"Severe Aplastic Anemia","enrollment":207},{"nctId":"NCT00719888","phase":"PHASE2","title":"Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2005-11-18","conditions":"Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":135},{"nctId":"NCT02618577","phase":"PHASE3","title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes","status":"TERMINATED","sponsor":"Atrial Fibrillation Network","startDate":"2016-02","conditions":"Atrial High Rate Episodes","enrollment":2608},{"nctId":"NCT03710044","phase":"PHASE4","title":"Investigation of Flare and Remission in Subjects With Atopic Dermatitis","status":"WITHDRAWN","sponsor":"LEO Pharma","startDate":"2019-01-14","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT04681833","phase":"PHASE2","title":"Safety and Efficacy of BARS13 in the Elderly","status":"COMPLETED","sponsor":"Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.","startDate":"2021-05-24","conditions":"Respiratory Syncytial Virus Infections","enrollment":125},{"nctId":"NCT02416388","phase":"PHASE2, PHASE3","title":"Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2015-01","conditions":"Acute Myeloid Leukemia (AML)","enrollment":3100},{"nctId":"NCT03902665","phase":"PHASE2","title":"Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2019-03-15","conditions":"Acute Myeloid Leukemia, Adult","enrollment":19},{"nctId":"NCT05839314","phase":"PHASE4","title":"Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2023-05-09","conditions":"Nephropathy, Glomerular Diseases, Idiopathic Membranous Nephropathy","enrollment":480},{"nctId":"NCT06004752","phase":"PHASE2","title":"Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2023-08-17","conditions":"Aplastic Anemia","enrollment":30},{"nctId":"NCT04107675","phase":"PHASE2","title":"A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)","status":"TERMINATED","sponsor":"Zambon SpA","startDate":"2020-02-11","conditions":"Bronchiolitis Obliterans Syndrome (BOS), GVHD, Chronic, Stem Cell Transplant Complications","enrollment":6},{"nctId":"NCT00003838","phase":"PHASE2","title":"Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1999-04-15","conditions":"Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia","enrollment":202},{"nctId":"NCT05936086","phase":"NA","title":"A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH","status":"RECRUITING","sponsor":"shifeng Lou","startDate":"2023-04-20","conditions":"Hemophagocytic Syndrome","enrollment":160},{"nctId":"NCT00070291","phase":"PHASE2","title":"Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma","status":"TERMINATED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2006-01-24","conditions":"Lymphoma","enrollment":4},{"nctId":"NCT00074269","phase":"PHASE2","title":"Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2003-07","conditions":"Breast Cancer","enrollment":5},{"nctId":"NCT03270748","phase":"PHASE2","title":"Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies","status":"COMPLETED","sponsor":"Gruppo Italiano Trapianto di Midollo Osseo","startDate":"2020-01-15","conditions":"Myeloid Malignancies","enrollment":78},{"nctId":"NCT02345850","phase":"PHASE3","title":"Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2015-08","conditions":"Acute Leukemia, Myelodysplasia","enrollment":346},{"nctId":"NCT05691764","phase":"NA","title":"Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2020-09-01","conditions":"Myocardial Injury, Cardiac Surgery","enrollment":40},{"nctId":"NCT00119366","phase":"PHASE2","title":"Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2003-05","conditions":"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)","enrollment":18},{"nctId":"NCT01682226","phase":"PHASE2","title":"Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-09-05","conditions":"Leukemia, Myelodysplastic Syndrome, Lymphoma","enrollment":84},{"nctId":"NCT00579527","phase":"PHASE1, PHASE2","title":"Phase I/II Thymus Transplantation With Immunosuppression #950","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2005-12-19","conditions":"DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly","enrollment":14},{"nctId":"NCT00412360","phase":"PHASE3","title":"Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2006-12","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":224},{"nctId":"NCT02328755","phase":"PHASE1, PHASE2","title":"Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2015-01","conditions":"Acute Myeloid Leukemia","enrollment":37},{"nctId":"NCT04622956","phase":"PHASE1, PHASE2","title":"GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2020-10-07","conditions":"Graft Vs Host Disease, Hematopoietic Neoplasm","enrollment":47},{"nctId":"NCT02435901","phase":"PHASE1, PHASE2","title":"HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2008-12","conditions":"Sickle Cell Disease, Beta Thalassemia-Major","enrollment":29},{"nctId":"NCT04878770","phase":"NA","title":"NMF-CsA-Dupi Trial","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2021-08-16","conditions":"Dermatitis, Atopic","enrollment":318},{"nctId":"NCT01434472","phase":"PHASE2","title":"High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2011-11-16","conditions":"Post-Transplant Lymphoproliferative Disorder, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma","enrollment":20},{"nctId":"NCT01690520","phase":"PHASE2","title":"Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Nohla Therapeutics, Inc.","startDate":"2012-12-11","conditions":"Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission","enrollment":163},{"nctId":"NCT04851977","phase":"PHASE1","title":"A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants","status":"COMPLETED","sponsor":"Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.","startDate":"2018-10-16","conditions":"Respiratory Syncytial Virus Infections","enrollment":60},{"nctId":"NCT04342988","phase":"PHASE4","title":"Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery","status":"COMPLETED","sponsor":"Research Insight LLC","startDate":"2020-04-08","conditions":"Dry Eye Syndromes","enrollment":74},{"nctId":"NCT03339401","phase":"PHASE2","title":"The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation","status":"TERMINATED","sponsor":"Jazz Pharmaceuticals","startDate":"2017-12-22","conditions":"Adenovirus","enrollment":29},{"nctId":"NCT01830010","phase":"PHASE1","title":"A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-06-28","conditions":"Hematological Malignancies","enrollment":23},{"nctId":"NCT04202887","phase":"NA","title":"The Effect of Low-Dose vs High-Dose Epidural Fentanyl on Gastric Emptying - A Prospective Double-Blinded Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-07-30","conditions":"Effects of; Anesthesia, Spinal and Epidural, in Pregnancy, Aspiration","enrollment":81},{"nctId":"NCT00309842","phase":"PHASE2","title":"Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-07-28","conditions":"Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":213},{"nctId":"NCT00345865","phase":"PHASE2","title":"Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-08-24","conditions":"Lymphoma","enrollment":473},{"nctId":"NCT00303719","phase":"PHASE2","title":"Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-03-26","conditions":"Kidney Cancer, Leukemia, Lymphoma","enrollment":342},{"nctId":"NCT00553202","phase":"PHASE2","title":"Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-01","conditions":"Leukemia","enrollment":158},{"nctId":"NCT00003954","phase":"PHASE1, PHASE2","title":"Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1999-03","conditions":"Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma","enrollment":40},{"nctId":"NCT00006251","phase":"PHASE1, PHASE2","title":"Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2000-05","conditions":"Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma","enrollment":21},{"nctId":"NCT01300572","phase":"PHASE1","title":"Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2012-01","conditions":"Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia","enrollment":16},{"nctId":"NCT00085449","phase":"PHASE1, PHASE2","title":"Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer","status":"WITHDRAWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2006-05","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":""},{"nctId":"NCT00008177","phase":"PHASE1","title":"Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1999-07-27","conditions":"Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q)","enrollment":79},{"nctId":"NCT04113915","phase":"","title":"Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy","status":"UNKNOWN","sponsor":"Safaa AA Khaled","startDate":"2019-11","conditions":"ITP - Immune Thrombocytopenic Purpura, Viral Hepatitis","enrollment":150},{"nctId":"NCT04128358","phase":"NA","title":"Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-11","conditions":"Idiopathic Thrombocytopenic Purpura","enrollment":180},{"nctId":"NCT02167958","phase":"PHASE1","title":"Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source","status":"COMPLETED","sponsor":"Rafic Farah, MD","startDate":"2015-02-11","conditions":"Leukemia, MDS, Myelofibrosis","enrollment":28},{"nctId":"NCT00104858","phase":"PHASE2","title":"Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2004-12","conditions":"Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma","enrollment":66},{"nctId":"NCT00383448","phase":"PHASE2","title":"HSCT for High Risk Inherited Inborn Errors","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2006-09","conditions":"Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy","enrollment":38},{"nctId":"NCT01180036","phase":"PHASE2, PHASE3","title":"MEmbranous Nephropathy Trial Of Rituximab","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-11","conditions":"Idiopathic Membranous Nephropathy","enrollment":130},{"nctId":"NCT03886233","phase":"","title":"Treatment Outcome of Uveitis in Autoimmune Diseases","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03","conditions":"Autoimmune Uveitis","enrollment":1},{"nctId":"NCT03170323","phase":"PHASE4","title":"Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy","status":"UNKNOWN","sponsor":"Guangdong Provincial People's Hospital","startDate":"2018-07-01","conditions":"Idiopathic Membranous Nephropathy","enrollment":128},{"nctId":"NCT00520130","phase":"PHASE1, PHASE2","title":"Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-10-30","conditions":"Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease","enrollment":92},{"nctId":"NCT00074490","phase":"PHASE2","title":"Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-01-01","conditions":"Lymphoma, Leukemia, Myeloproliferative Disorders","enrollment":442},{"nctId":"NCT00002831","phase":"PHASE1, PHASE2","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1995-08-01","conditions":"Leukemia","enrollment":24},{"nctId":"NCT03408223","phase":"NA","title":"Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia","status":"UNKNOWN","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2014-03","conditions":"Acute Leukemia","enrollment":100},{"nctId":"NCT00185614","phase":"PHASE2","title":"Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma","status":"COMPLETED","sponsor":"Wen-Kai Weng","startDate":"2000-08","conditions":"Blood Cancer, Multiple Myeloma","enrollment":63},{"nctId":"NCT00609739","phase":"PHASE1, PHASE2","title":"Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"1999-06","conditions":"Leukemia","enrollment":1},{"nctId":"NCT00303667","phase":"PHASE1, PHASE2","title":"Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-01","conditions":"Acute Myelogenous Leukemia","enrollment":50},{"nctId":"NCT00354172","phase":"PHASE2","title":"Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2006-02","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":16},{"nctId":"NCT01626092","phase":"NA","title":"Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-07-11","conditions":"Lysosomal Storage Disease, Peroxisomal Disorder","enrollment":3},{"nctId":"NCT00376519","phase":"PHASE1","title":"Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2007-05","conditions":"Graft Versus Host Disease, Leukemia, Lymphoma","enrollment":3},{"nctId":"NCT00899847","phase":"PHASE2","title":"Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-05","conditions":"Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma","enrollment":9},{"nctId":"NCT00245037","phase":"PHASE1, PHASE2","title":"Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer","status":"COMPLETED","sponsor":"OHSU Knight Cancer Institute","startDate":"2005-06","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":147},{"nctId":"NCT00281879","phase":"PHASE2","title":"Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2006-02","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":200},{"nctId":"NCT00988715","phase":"PHASE1","title":"Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2010-04-21","conditions":"Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome","enrollment":17},{"nctId":"NCT02653196","phase":"EARLY_PHASE1","title":"A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2015-09","conditions":"Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":1},{"nctId":"NCT02728271","phase":"EARLY_PHASE1","title":"Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome","status":"TERMINATED","sponsor":"Mounzer Agha","startDate":"2016-04","conditions":"Churg-Strauss Syndrome","enrollment":1},{"nctId":"NCT00863148","phase":"PHASE2","title":"Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2009-10","conditions":"MDS, AML, ALL","enrollment":30},{"nctId":"NCT01313923","phase":"EARLY_PHASE1","title":"Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus","status":"TERMINATED","sponsor":"University of California, Irvine","startDate":"2011-02","conditions":"Pemphigus","enrollment":3},{"nctId":"NCT00043979","phase":"PHASE2","title":"Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2002-09-19","conditions":"Sarcoma","enrollment":60},{"nctId":"NCT01797315","phase":"PHASE4","title":"Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol","status":"TERMINATED","sponsor":"University Hospital of Berlin","startDate":"2007-03","conditions":"Renal Transplant Patients at High-risk for Skin Cancer","enrollment":40},{"nctId":"NCT01830920","phase":"PHASE2","title":"A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)","status":"COMPLETED","sponsor":"Thrasos Innovation, Inc.","startDate":"2013-05","conditions":"Acute Kidney Injury","enrollment":452},{"nctId":"NCT00698685","phase":"PHASE2","title":"Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation","status":"TERMINATED","sponsor":"University of Arizona","startDate":"2006-01-23","conditions":"Leukemia, Lymphoma, Hodgkin's Disease","enrollment":14},{"nctId":"NCT01954784","phase":"PHASE1","title":"Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2013-10-07","conditions":"Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma","enrollment":8},{"nctId":"NCT00504543","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-07","conditions":"Kidney Transplantation","enrollment":311},{"nctId":"NCT01222039","phase":"PHASE1, PHASE2","title":"Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.","status":"COMPLETED","sponsor":"Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud","startDate":"2010-06","conditions":"Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease, Immune System Diseases","enrollment":19},{"nctId":"NCT00023244","phase":"PHASE2","title":"Steroid Withdrawal in Pediatric Kidney Transplant Recipients","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-01","conditions":"End-Stage Renal Disease","enrollment":274},{"nctId":"NCT02706470","phase":"PHASE2, PHASE3","title":"Use of Cyclosporin A for the Treatment of Recurrent Miscarriage","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2016-05","conditions":"Miscarriage, Recurrent","enrollment":384},{"nctId":"NCT00597519","phase":"PHASE2","title":"A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-03","conditions":"Cancer, Leukemia, Myelodysplastic Syndrome","enrollment":28},{"nctId":"NCT00874315","phase":"PHASE2","title":"Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.","status":"WITHDRAWN","sponsor":"Nationwide Children's Hospital","startDate":"2008-09","conditions":"Neuroblastoma","enrollment":""},{"nctId":"NCT01067300","phase":"PHASE3","title":"A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2010-02","conditions":"Leukemia","enrollment":198},{"nctId":"NCT02461121","phase":"PHASE3","title":"HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk","status":"COMPLETED","sponsor":"The Affiliated Hospital of the Chinese Academy of Military Medical Sciences","startDate":"2004-05","conditions":"Acute Myeloid Leukemia","enrollment":156}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CsA high dose","genericName":"CsA high dose","companyName":"Fovea Pharmaceuticals SA","companyId":"fovea-pharmaceuticals-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Calcineurin inhibitor Used for Organ transplantation.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}